[1]
2026. Comparison of Outcomes of Linagliptin Plus Insulin and Insulin Only Among Type II Diabetes Mellitus Patients with Chronic Kidney Disease. Medical Forum Monthly. 37, 3 (Apr. 2026). DOI:https://doi.org/10.60110/medforum.370314.